Related Experiment Video
Updated: Nov 7, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Functional landscape of SARS-CoV-2 cellular restriction
Laura Martin-Sancho1, Mary K Lewinski2, Lars Pache1
1Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Abstract:
A deficient interferon (IFN) response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been implicated as a determinant of severe coronavirus disease 2019 (COVID-19). To identify the molecular effectors that govern IFN control of SARS-CoV-2 infection, we conducted a large-scale gain-of-function analysis that evaluated the impact of human IFN-stimulated genes (ISGs) on viral replication. A limited subset of ISGs were found to control viral infection, including endosomal factors inhibiting viral entry, RNA binding proteins suppressing viral RNA synthesis, and a highly enriched cluster of endoplasmic reticulum (ER)/Golgi-resident ISGs inhibiting viral assembly/egress. These included broad-acting antiviral ISGs and eight ISGs that specifically inhibited SARS-CoV-2 and SARS-CoV-1 replication. Among the broad-acting ISGs was BST2/tetherin, which impeded viral release and is antagonized by SARS-CoV-2 Orf7a protein. Overall, these data illuminate a set of ISGs that underlie innate immune control of SARS-CoV-2/SARS-CoV-1 infection, which will facilitate the understanding of host determinants that impact disease severity and offer potential therapeutic strategies for COVID-19.
Insights
A weak interferon response contributes to severe COVID-19. Researchers identified specific interferon-stimulated genes (ISGs) that control SARS-CoV-2 replication, offering potential therapeutic targets for severe coronavirus disease 2019.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- A deficient interferon (IFN) response is linked to severe coronavirus disease 2019 (COVID-19).
- Understanding the molecular mechanisms of IFN control over SARS-CoV-2 is crucial for managing severe infections.
Purpose of the Study:
- To identify specific human interferon-stimulated genes (ISGs) that inhibit SARS-CoV-2 replication.
- To elucidate the roles of ISGs in innate immune control against SARS-CoV-2 and SARS-CoV-1.
Main Methods:
- Conducted a large-scale gain-of-function analysis of human ISGs.
- Evaluated the impact of ISGs on SARS-CoV-2 viral replication and entry.
- Investigated specific ISGs, including BST2/tetherin and its interaction with SARS-CoV-2 Orf7a.
Main Results:
- A subset of ISGs demonstrated significant control over viral infection.
- Identified ISGs involved in inhibiting viral entry, RNA synthesis, and assembly/egress.
- Discovered eight ISGs specifically inhibiting SARS-CoV-2 and SARS-CoV-1, including BST2/tetherin which restricts viral release.
Conclusions:
- These findings highlight key ISGs essential for innate immune defense against SARS-CoV-2 and SARS-CoV-1.
- The identified ISGs provide insights into host determinants of COVID-19 severity.
- This research offers potential therapeutic strategies for COVID-19 by targeting specific ISGs.
Related Concept Videos
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Size and Structure of Viral Genomes
Retrovirus Life Cycles
Intracellular Movement of Viruses and Bacteria
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Outer Layers of the Cell Envelope

